Abstract:This review is concerned with evaluating the toxicity associated with human exposure to silver and gold nanoparticles (NPs), due to the relative abundance of toxicity data available for these particles, when compared to other metal particulates. This has allowed knowledge on the current understanding of the field to be gained, and has demonstrated where gaps in knowledge are. It is anticipated that evaluating the hazards associated with silver and gold particles will ultimately enable risk assessments to be completed, by combining this information with knowledge on the level of human exposure. The quantity of available hazard information for metals is greatest for silver particulates, due to its widespread inclusion within a number of diverse products (including clothes and wound dressings), which primarily arises from its antibacterial behaviour. Gold has been used on numerous occasions to assess the biodistribution and cellular uptake of NPs following exposure. Inflammatory, oxidative, genotoxic, and cytotoxic consequences are associated with silver particulate exposure, and are inherently linked. The primary site of gold and silver particulate accumulation has been consistently demonstrated to be the liver, and it is therefore relevant that a number of in vitro investigations have focused on this potential target organ. However, in general there is a lack of in vivo and in vitro toxicity information that allows correlations between the findings to be made. Instead a focus on the tissue distribution of particles following exposure is evident within the available literature, which can be useful in directing appropriate in vitro experimentation by revealing potential target sites of toxicity. The experimental design has the potential to impact on the toxicological observations, and in particular the use of excessively high particle concentrations has been observed. As witnessed for other particle types, gold and silver particle sizes are influential in dictating the observed toxicity, with smaller particles exhibiting a greater response than their larger counterparts, and this is likely to be driven by differences in particle surface area, when administered at an equal-mass dose. A major obstacle, at present, is deciphering whether the responses related to silver nanoparticulate exposure derive from their small size, or particle dissolution contributes to the observed toxicity. Alternatively, a combination of both may be responsible, as the release of ions would be expected to be greater for smaller particles.

Comparisons of the biodistribution and toxicological examinations after repeated intravenous administration of silver and gold nanoparticles in mice

Toxicity of nano- and micro-sized silver particles in human hepatocyte cell line L02

The Systematic Evaluation of Size-Dependent Toxicity and Multi-Time Biodistribution of Gold Nanoparticles.

Toxicologic Effects of Gold Nanoparticles in Vivo by Different Administration Routes

Acute Toxic Effects and Gender‐related Biokinetics of Silver Nanoparticles Following an Intravenous Injection in Mice

Bio-distribution and Bio-Availability of Silver and Gold in Rat Tissues with Silver/gold Nanorod Administration

Biodistribution and organ oxidative damage following 28 days oral administration of nanosilver with/without coating in mice

Toxicity of gold nanoparticles (AuNPs): A review

Toxicological Evaluation of Silver Nanoparticles and Silver Nitrate in Rats Following 28 Days of Repeated Oral Exposure

Cytotoxicity and Genotoxicity Assessment of Silver Nanoparticles in Mouse

A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity

Evaluation of the biological fate and the transport through biological barriers of nanosilver in mice.

The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity

Shape Dependence Of Gold Nanoparticles On In Vivo Acute Toxicological Effects And Biodistribution

Silver Nanoparticles Induced Oxidative and Endoplasmic Reticulum Stresses in Mouse Tissues: Implications for the Development of Acute Toxicity after Intravenous Administration.

Distribution, Translocation and Accumulation of Silver Nanoparticles in Rats.

Biosafety risk assessment of gold and aluminum nanoparticles in tumor-bearing mice

The biodistribution and transformation of nanoparticulate and ionic silver in rat organs in vivo

Size-dependent in Vivo Toxicity of PEG-coated Gold Nanoparticles

Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles

Long-Term Accumulation, Biological Effects and Toxicity of BSA-Coated Gold Nanoparticles in the Mouse Liver, Spleen, and Kidneys